What is BrightSpring Health Services' operating income?

BrightSpring Health Services' total operating income in 2025 was $295.25 million, based on the following breakdown: Total Gross Profit: $1.52 billion Total Operating Expenses: $1.22 billion

BrightSpring Health Services (BTSGU) Financials

$207.70 +0.51 (+0.25%)

Closing price 08/5/2026 03:57 PM Eastern

Extended Trading

$207.70 +0.00 (+0.00%)

As of 04:03 AM Eastern

Compare

Annual Income Statements for BrightSpring Health Services

This table shows BrightSpring Health Services' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-54	-155	-18	191
Consolidated Net Income / (Loss)	-54	-157	-21	189
Net Income / (Loss) Continuing Operations	-54	-182	-69	105
Total Pre-Tax Income	-46	-214	-95	138
Total Operating Income	188	58	108	295
Total Gross Profit	1,354	1,139	1,266	1,518
Total Revenue	7,721	7,691	10,072	12,911
Operating Revenue	7,721	7,691	10,072	12,911
Total Cost of Revenue	6,366	6,552	8,806	11,393
Operating Cost of Revenue	6,366	6,552	8,806	11,393
Total Operating Expenses	1,166	1,081	1,158	1,223
Selling, General & Admin Expense	1,126	1,081	1,158	1,223
Total Other Income / (Expense), net	-234	-272	-203	-157
Interest Expense	234	272	203	157
Income Tax Expense	8.47	-32	-26	33
Net Income / (Loss) Discontinued Operations	-	25	48	84
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.31	-2.23	-2.46	-1.55
Basic Earnings per Share	($0.46)	($1.31)	($0.09)	$0.94
Weighted Average Basic Shares Outstanding	117.84M	117.87M	193.00M	202.56M
Diluted Earnings per Share	($0.46)	($1.31)	($0.09)	$0.87
Weighted Average Diluted Shares Outstanding	117.84M	117.87M	193.00M	219.77M
Weighted Average Basic & Diluted Shares Outstanding	-	-	174.97M	193.54M

This table shows BrightSpring Health Services' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	-6.54	-46	20	-8.23	16	30	28	56	77	149	84
Consolidated Net Income / (Loss)	-7.20	-46	19	-8.98	15	29	28	55	77	149	84
Net Income / (Loss) Continuing Operations	-7.20	-56	8.49	-26	15	9.22	8.54	37	50	74	87
Total Pre-Tax Income	-15	-83	-4.63	-18	24	8.98	9.78	50	70	83	94
Total Operating Income	68	-15	39	29	79	51	49	88	108	121	130
Total Gross Profit	369	292	312	323	422	338	375	392	413	482	493
Total Revenue	2,375	2,286	2,438	2,601	3,053	2,878	3,148	3,334	3,551	3,614	3,873
Operating Revenue	2,375	2,286	2,438	2,601	3,053	2,878	3,148	3,334	3,551	3,614	3,873
Total Cost of Revenue	2,006	1,993	2,126	2,278	2,631	2,540	2,773	2,942	3,138	3,131	3,380
Operating Cost of Revenue	2,006	1,993	2,126	2,278	2,631	2,540	2,773	2,942	3,138	3,131	3,380
Total Operating Expenses	300	308	274	294	343	288	326	304	304	361	362
Selling, General & Admin Expense	300	308	274	294	343	288	326	304	304	361	362
Total Other Income / (Expense), net	-83	-67	-43	-47	-55	-42	-39	-38	-39	-39	-37
Interest Expense	83	67	43	47	55	42	39	38	39	39	37
Income Tax Expense	-7.59	-27	-13	8.16	8.78	-0.24	1.24	12	20	8.55	6.91
Net Income / (Loss) Discontinued Operations	-	9.64	11	17	-	20	19	18	28	74	-2.40
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.66	-0.64	-0.48	-0.75	-0.60	-0.53	-0.67	-0.60	0.24	-0.16	-0.08
Basic Earnings per Share	($0.05)	($0.26)	$0.10	($0.04)	$0.11	$0.15	$0.14	$0.27	$0.38	$0.73	$0.41
Weighted Average Basic Shares Outstanding	117.87M	175.53M	197.52M	198.49M	193.00M	201.01M	201.81M	203.49M	202.56M	204.71M	206.04M
Diluted Earnings per Share	($0.05)	($0.26)	$0.10	($0.04)	$0.11	$0.14	$0.13	$0.26	$0.34	$0.67	$0.38
Weighted Average Diluted Shares Outstanding	117.87M	175.53M	208.99M	198.49M	193.00M	214.93M	216.34M	217.98M	219.77M	221.32M	220.28M
Weighted Average Basic & Diluted Shares Outstanding	0.00	171.32M	171.46M	174.13M	174.97M	174.25M	177.15M	180.35M	193.54M	193.92M	197.86M

This table details how cash moves in and out of BrightSpring Health Services' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-33	-0.56	48	27
Net Cash From Operating Activities	-4.65	211	24	490
Net Cash From Continuing Operating Activities	-4.65	211	24	490
Net Income / (Loss) Continuing Operations	-54	-157	-21	189
Consolidated Net Income / (Loss)	-54	-157	-21	189
Depreciation Expense	204	202	204	164
Amortization Expense	20	21	12	11
Non-Cash Adjustments To Reconcile Net Income	78	38	124	129
Changes in Operating Assets and Liabilities, net	-252	107	-296	-3.70
Net Cash From Investing Activities	45	-134	-140	-305
Net Cash From Continuing Investing Activities	45	-134	-140	-305
Purchase of Property, Plant & Equipment	-70	-74	-81	-95
Acquisitions	-42	-63	-60	-205
Other Investing Activities, net	2.14	2.15	0.47	-5.03
Net Cash From Financing Activities	-74	-77	165	-158
Net Cash From Continuing Financing Activities	-74	-77	165	-158
Repayment of Debt	-41	-30	-3,443	-50
Repurchase of Preferred Equity	0.00	-10	0.00	0.00
Repurchase of Common Equity	0.00	-0.65	-2.97	-48
Issuance of Debt	-17	-24	2,968	-63
Issuance of Common Equity	0.23	1.33	658	25
Other Financing Activities, net	-15	-13	-15	-21
Cash Interest Paid	213	304	211	184
Cash Income Taxes Paid	29	37	25	27

This table details how cash moves in and out of BrightSpring Health Services' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	1.43	45	-33	11	25	-8.61	18	71	-53	800	-338
Net Cash From Operating Activities	162	-79	-15	27	91	102	49	108	232	123	44
Net Cash From Continuing Operating Activities	162	-79	-15	27	91	102	49	108	232	123	44
Net Income / (Loss) Continuing Operations	-7.20	-46	19	-8.98	15	29	28	55	77	149	84
Consolidated Net Income / (Loss)	-7.20	-46	19	-8.98	15	29	28	55	77	149	84
Depreciation Expense	51	49	50	51	55	42	42	41	40	39	41
Amortization Expense	5.23	4.45	2.49	2.54	2.63	2.75	2.79	2.84	2.86	2.82	2.95
Non-Cash Adjustments To Reconcile Net Income	7.49	46	21	27	30	28	55	20	26	-96	32
Changes in Operating Assets and Liabilities, net	106	-132	-108	-44	-12	-0.72	-78	-11	86	29	-117
Net Cash From Investing Activities	-17	-31	-58	-36	-16	-24	-23	-24	-234	747	-28
Net Cash From Continuing Investing Activities	-17	-31	-58	-36	-16	-24	-23	-24	-234	747	-28
Purchase of Property, Plant & Equipment	-17	-22	-24	-20	-15	-18	-24	-16	-38	-22	-29
Other Investing Activities, net	0.36	0.27	0.27	0.36	-0.43	0.20	1.18	-6.45	0.04	0.23	0.83
Net Cash From Financing Activities	-144	155	40	20	-50	-86	-8.24	-13	-50	-70	-354
Net Cash From Continuing Financing Activities	-144	155	40	20	-50	-86	-8.24	-13	-50	-70	-354
Repayment of Debt	-7.58	-3,453	-2,527	-14	-16	-12	-12	-14	51	-12	-312
Repurchase of Common Equity	-0.33	-0.63	-0.33	-2.02	-	-5.10	-	-	-43	-60	-60
Issuance of Common Equity	0.74	656	0.40	0.13	1.00	0.35	8.72	5.62	11	12	20
Other Financing Activities, net	-4.42	-3.08	-4.13	-6.22	-1.20	-6.17	-5.03	-4.51	-5.58	-9.76	-2.67
Cash Interest Paid	78	60	51	54	46	54	42	42	46	43	33
Cash Income Taxes Paid	1.86	11	13	0.62	0.64	0.25	13	1.83	12	0.40	156

This table presents BrightSpring Health Services' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2023	2024	2025
Period end date	12/31/2023	12/31/2024	12/31/2025
Total Assets	5,533	5,926	6,413
Total Current Assets	1,457	1,893	2,894
Cash & Equivalents	13	61	88
Accounts Receivable	882	903	990
Inventories, net	403	637	815
Prepaid Expenses	159	161	119
Other Current Nonoperating Assets	-	131	882
Plant, Property, & Equipment, net	246	181	205
Total Noncurrent Assets	3,830	3,853	3,315
Goodwill	2,608	2,364	2,546
Intangible Assets	881	595	558
Other Noncurrent Operating Assets	340	200	211
Total Liabilities & Shareholders' Equity	5,533	5,926	6,413
Total Liabilities	4,920	4,275	4,527
Total Current Liabilities	1,248	1,428	1,849
Short-Term Debt	32	49	52
Accounts Payable	642	924	1,218
Accrued Expenses	492	296	333
Other Current Liabilities	82	42	50
Other Current Nonoperating Liabilities	-	118	196
Total Noncurrent Liabilities	3,672	2,846	2,678
Long-Term Debt	3,332	2,562	2,455
Capital Lease Obligations	224	136	150
Noncurrent Deferred & Payable Income Tax Liabilities	24	0.00	6.18
Other Noncurrent Operating Liabilities	92	71	67
Redeemable Noncontrolling Interest	27	3.73	11
Total Equity & Noncontrolling Interests	585	1,648	1,875
Total Preferred & Common Equity	585	1,648	1,875
Preferred Stock	0.00	0.00	0.00
Total Common Equity	585	1,648	1,875
Common Stock	773	1,869	1,956
Retained Earnings	-200	-222	-75
Accumulated Other Comprehensive Income / (Loss)	13	1.42	-6.69
Noncontrolling Interest	0.67	0.00	0.07

This table presents BrightSpring Health Services' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026
Total Assets	5,656	5,605	5,786	5,847	5,944	6,049	6,213	5,986
Total Current Assets	1,573	1,522	1,710	2,528	2,648	2,780	2,689	2,470
Cash & Equivalents	58	25	36	52	70	140	889	550
Accounts Receivable	991	985	1,026	975	973	1,013	1,114	1,139
Inventories, net	374	374	478	534	625	639	560	575
Prepaid Expenses	150	138	170	131	129	124	127	205
Other Current Nonoperating Assets	-	-	-	836	850	864	0.00	0.00
Plant, Property, & Equipment, net	246	246	249	177	178	175	202	214
Total Noncurrent Assets	3,837	3,838	3,828	3,141	3,118	3,094	3,322	3,302
Goodwill	2,609	2,626	2,673	2,370	2,370	2,371	2,534	2,535
Intangible Assets	856	851	842	568	544	522	537	514
Other Noncurrent Operating Assets	361	338	306	201	200	202	252	252
Total Liabilities & Shareholders' Equity	5,656	5,605	5,786	5,847	5,944	6,049	6,213	5,986
Total Liabilities	4,081	3,999	4,167	4,156	4,198	4,228	4,223	3,928
Total Current Liabilities	1,245	1,145	1,264	1,458	1,505	1,550	1,548	1,556
Short-Term Debt	49	49	49	49	51	52	53	41
Accounts Payable	656	669	784	868	965	954	1,091	1,091
Accrued Expenses	452	347	349	303	253	304	352	372
Other Current Liabilities	89	80	82	42	42	43	52	52
Other Current Nonoperating Liabilities	-	-	-	196	194	197	0.00	0.00
Total Noncurrent Liabilities	2,836	2,854	2,903	2,699	2,693	2,679	2,675	2,372
Long-Term Debt	2,515	2,564	2,609	2,489	2,478	2,465	2,445	2,149
Capital Lease Obligations	24	220	221	137	141	139	150	145
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	0.00	0.00	0.00	0.00	10	1.17	0.64
Other Noncurrent Operating Liabilities	297	71	74	73	74	64	79	77
Redeemable Noncontrolling Interest	6.28	5.94	4.13	3.32	2.82	2.36	11	9.42
Total Equity & Noncontrolling Interests	1,568	1,600	1,615	1,687	1,743	1,819	1,979	2,049
Total Preferred & Common Equity	1,567	1,600	1,615	1,687	1,743	1,819	1,979	2,049
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,567	1,600	1,615	1,687	1,743	1,819	1,979	2,049
Common Stock	1,790	1,807	1,850	1,882	1,912	1,933	1,966	2,006
Retained Earnings	-246	-226	-234	-193	-164	-109	14	38
Accumulated Other Comprehensive Income / (Loss)	23	19	-0.71	-1.87	-4.33	-6.29	-1.27	4.19
Noncontrolling Interest	0.52	0.38	0.20	-0.13	-0.28	0.09	0.06	0.07

This table displays calculated financial ratios and metrics derived from BrightSpring Health Services' official financial filings.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	14.32%	27.65%	28.18%
EBITDA Growth	0.00%	-10.14%	14.18%	45.06%
EBIT Growth	0.00%	-21.64%	40.22%	173.50%
NOPAT Growth	0.00%	-21.64%	40.22%	196.83%
Net Income Growth	0.00%	-189.26%	86.92%	1,021.56%
EPS Growth	0.00%	-184.78%	93.13%	1,066.67%
Operating Cash Flow Growth	0.00%	4,630.05%	-88.72%	1,961.79%
Free Cash Flow Firm Growth	0.00%	0.00%	102.61%	-69.59%
Invested Capital Growth	0.00%	0.00%	0.91%	1.53%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	-2.94%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	-11.47%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	-13.44%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	-15.74%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	48.68%
EPS Q/Q Growth	0.00%	0.00%	0.00%	35.94%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	40.36%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-84.16%
Invested Capital Q/Q Growth	0.00%	0.00%	-5.28%	2.71%
Profitability Metrics	-	-	-	-
Gross Margin	17.54%	16.24%	14.10%	11.76%
EBITDA Margin	5.34%	4.20%	3.75%	3.65%
Operating Margin	2.43%	1.67%	1.83%	2.29%
EBIT Margin	2.43%	1.67%	1.83%	2.29%
Profit (Net Income) Margin	-0.70%	-1.78%	-0.18%	1.46%
Tax Burden Percent	118.50%	88.40%	59.07%	137.10%
Interest Burden Percent	-24.36%	-120.54%	-16.83%	46.72%
Effective Tax Rate	0.00%	0.00%	0.00%	24.03%
Return on Invested Capital (ROIC)	0.00%	4.92%	3.43%	6.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-9.62%	-1.93%	4.21%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-56.13%	-5.25%	4.69%
Return on Equity (ROE)	0.00%	-51.21%	-1.81%	10.69%
Cash Return on Invested Capital (CROIC)	0.00%	-195.08%	2.53%	4.48%
Operating Return on Assets (OROA)	0.00%	2.66%	3.60%	4.79%
Return on Assets (ROA)	0.00%	-2.83%	-0.36%	3.07%
Return on Common Equity (ROCE)	0.00%	-48.88%	-1.79%	10.65%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-26.82%	-1.25%	0.00%
Net Operating Profit after Tax (NOPAT)	131	103	144	224
NOPAT Margin	1.70%	1.17%	1.28%	1.74%
Net Nonoperating Expense Percent (NNEP)	0.00%	14.54%	5.37%	1.78%
Return On Investment Capital (ROIC_SIMPLE)	-	2.47%	3.37%	4.95%
Cost of Revenue to Revenue	82.46%	83.76%	85.90%	88.24%
SG&A Expenses to Revenue	14.58%	14.58%	12.27%	9.47%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	15.11%	14.58%	12.27%	9.47%
Earnings before Interest and Taxes (EBIT)	188	147	206	295
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	412	370	423	471
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	1.19	1.80	3.60
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.09	0.08	0.26	0.52
Price to Earnings (P/E)	0.00	0.00	0.00	35.42
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	2.82%
Enterprise Value to Invested Capital (EV/IC)	0.00	1.03	1.31	2.48
Enterprise Value to Revenue (EV/Rev)	0.00	0.49	0.49	0.72
Enterprise Value to EBITDA (EV/EBITDA)	0.00	11.60	13.11	19.83
Enterprise Value to EBIT (EV/EBIT)	0.00	29.19	26.86	31.62
Enterprise Value to NOPAT (EV/NOPAT)	0.00	41.70	38.37	41.62
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	20.38	233.17	19.04
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	52.08	55.71
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	5.86	1.60	1.41
Long-Term Debt to Equity	0.00	5.81	1.57	1.38
Financial Leverage	0.00	5.84	2.72	1.11
Leverage Ratio	0.00	9.03	5.06	3.49
Compound Leverage Factor	0.00	-10.89	-0.85	1.63
Debt to Total Capital	0.00%	85.42%	61.48%	58.49%
Short-Term Debt to Total Capital	0.00%	0.77%	1.14%	1.15%
Long-Term Debt to Total Capital	0.00%	84.65%	60.34%	57.33%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.66%	0.09%	0.25%
Common Equity to Total Capital	0.00%	13.92%	38.44%	41.27%
Debt to EBITDA	0.00	9.69	6.23	5.65
Net Debt to EBITDA	0.00	9.65	6.09	5.46
Long-Term Debt to EBITDA	0.00	9.60	6.12	5.53
Debt to NOPAT	0.00	34.83	18.24	11.85
Net Debt to NOPAT	0.00	34.70	17.82	11.45
Long-Term Debt to NOPAT	0.00	34.52	17.91	11.61
Altman Z-Score	0.00	1.76	2.47	3.24
Noncontrolling Interest Sharing Ratio	0.00%	4.54%	1.39%	0.42%
Liquidity Ratios	-	-	-	-
Current Ratio	0.00	1.17	1.33	1.57
Quick Ratio	0.00	0.72	0.76	0.58
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-4,085	106	168
Operating Cash Flow to CapEx	-6.64%	286.67%	29.38%	513.35%
Free Cash Flow to Firm to Interest Expense	0.00	-12.58	0.44	1.07
Operating Cash Flow to Interest Expense	-0.02	0.65	0.10	3.12
Operating Cash Flow Less CapEx to Interest Expense	-0.32	0.42	-0.24	2.51
Efficiency Ratios	-	-	-	-
Asset Turnover	0.00	1.60	1.97	2.09
Accounts Receivable Turnover	0.00	10.01	11.80	13.64
Inventory Turnover	0.00	18.35	18.55	15.70
Fixed Asset Turnover	0.00	35.89	45.41	67.02
Accounts Payable Turnover	0.00	11.52	12.23	10.64
Days Sales Outstanding (DSO)	0.00	36.46	30.94	26.75
Days Inventory Outstanding (DIO)	0.00	19.89	19.67	23.26
Days Payable Outstanding (DPO)	0.00	31.68	29.85	34.31
Cash Conversion Cycle (CCC)	0.00	24.67	20.77	15.70
Capital & Investment Metrics	-	-	-	-
Invested Capital	0.00	4,188	4,226	3,769
Invested Capital Turnover	0.00	4.22	2.68	3.45
Increase / (Decrease) in Invested Capital	0.00	4,188	38	57
Enterprise Value (EV)	0.00	4,296	5,543	9,335
Market Capitalization	693	693	2,965	6,754
Book Value per Share	$0.00	$4.96	$9.46	$10.40
Tangible Book Value per Share	$0.00	($24.65)	($10.54)	($6.81)
Total Capital	0.00	4,201	4,287	4,544
Total Debt	0.00	3,588	2,636	2,658
Total Long-Term Debt	0.00	3,556	2,587	2,605
Net Debt	0.00	3,575	2,574	2,569
Capital Expenditures (CapEx)	70	74	81	95
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	227	452	1,009
Debt-free Net Working Capital (DFNWC)	0.00	240	513	1,097
Net Working Capital (NWC)	0.00	208	465	1,045
Net Nonoperating Expense (NNE)	186	260	165	35
Net Nonoperating Obligations (NNO)	0.00	3,575	2,574	1,883
Total Depreciation and Amortization (D&A)	224	223	217	176
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	2.58%	4.01%	7.82%
Debt-free Net Working Capital to Revenue	0.00%	2.72%	4.56%	8.50%
Net Working Capital to Revenue	0.00%	2.36%	4.12%	8.09%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($0.09)	$0.94
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	193.00M	202.56M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($0.09)	$0.87
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	193.00M	219.77M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	174.97M	193.54M
Normalized Net Operating Profit after Tax (NOPAT)	160	103	144	224
Normalized NOPAT Margin	2.07%	1.17%	1.28%	1.74%
Pre Tax Income Margin	-0.59%	-2.01%	-0.31%	1.07%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.80	0.45	0.86	1.88
NOPAT to Interest Expense	0.56	0.32	0.60	1.43
EBIT Less CapEx to Interest Expense	0.50	0.23	0.52	1.27
NOPAT Less CapEx to Interest Expense	0.26	0.09	0.26	0.82
Payout Ratios	-	-	-	-
Dividend Payout Ratio	-1.38%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-1.38%	-0.41%	-14.45%	25.53%

This table displays calculated financial ratios and metrics derived from BrightSpring Health Services' official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	193,536,850.00	193,918,398.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	193,536,850.00	193,918,398.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	0.77	0.43
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	27.03%	26.01%	28.82%	28.56%	25.92%	29.10%	28.17%	29.26%	25.56%	23.05%
EBITDA Growth	0.00%	-42.64%	-14.92%	2,870.24%	9.69%	151.48%	2.17%	59.81%	33.12%	70.79%	87.53%
EBIT Growth	0.00%	-84.35%	-21.61%	208.78%	15.81%	430.87%	25.62%	201.90%	94.66%	139.36%	168.53%
NOPAT Growth	0.00%	-84.35%	118.27%	-1,691.56%	5.36%	585.31%	56.74%	225.91%	203.00%	109.06%	184.74%
Net Income Growth	0.00%	-108.23%	602.86%	93.10%	313.91%	162.54%	41.67%	715.09%	401.95%	412.27%	205.75%
EPS Growth	0.00%	-44.44%	233.33%	96.40%	320.00%	153.85%	30.00%	750.00%	209.09%	378.57%	192.31%
Operating Cash Flow Growth	0.00%	-297.66%	39.59%	-19.13%	-44.20%	228.84%	422.34%	296.15%	155.55%	21.01%	-10.51%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	111.75%	117.48%	119.32%	-95.96%	-93.08%	-104.52%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	0.91%	-10.51%	-16.41%	-17.74%	1.53%	2.05%	4.21%
Revenue Q/Q Growth	5.23%	0.00%	5.96%	6.47%	5.02%	-5.72%	9.37%	5.92%	6.49%	1.78%	7.18%
EBITDA Q/Q Growth	3,262.11%	0.00%	87.15%	-4.34%	24.16%	-29.96%	-2.57%	41.04%	14.50%	8.55%	6.98%
EBIT Q/Q Growth	230.64%	0.00%	673.70%	-8.93%	39.08%	-35.82%	-4.30%	80.91%	23.08%	12.34%	7.36%
NOPAT Q/Q Growth	230.64%	0.00%	2,054.16%	-638.71%	107.68%	3.47%	-18.59%	56.52%	15.99%	41.45%	10.88%
Net Income Q/Q Growth	94.47%	0.00%	141.91%	-146.20%	271.52%	88.33%	-5.06%	100.57%	39.97%	92.20%	-43.34%
EPS Q/Q Growth	95.50%	0.00%	138.46%	-140.00%	375.00%	27.27%	-7.14%	100.00%	30.77%	97.06%	-43.28%
Operating Cash Flow Q/Q Growth	382.03%	0.00%	80.69%	278.96%	232.57%	12.12%	-51.70%	119.94%	114.53%	-46.91%	-64.28%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	-4.69%	-19.24%	100.24%	3,824.87%	58.61%	11.91%	-97.64%	65.28%	-203.69%
Invested Capital Q/Q Growth	0.00%	0.00%	7.51%	1.10%	-5.28%	-13.08%	0.42%	-0.51%	2.71%	-0.55%	2.54%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	15.53%	14.34%	14.25%	14.04%	13.82%	11.76%	11.91%	11.76%	11.62%	13.34%	12.72%
EBITDA Margin	5.24%	2.38%	4.21%	3.78%	4.47%	3.32%	2.96%	3.94%	4.24%	4.52%	4.51%
Operating Margin	2.87%	0.31%	2.29%	1.96%	2.59%	1.76%	1.54%	2.63%	3.04%	3.36%	3.37%
EBIT Margin	2.87%	0.31%	2.29%	1.96%	2.59%	1.76%	1.54%	2.63%	3.04%	3.36%	3.37%
Profit (Net Income) Margin	-0.30%	-1.80%	0.71%	-0.31%	0.50%	1.01%	0.88%	1.66%	2.18%	4.11%	2.17%
Tax Burden Percent	48.68%	66.57%	194.90%	-1,152.89%	63.69%	323.20%	281.64%	111.36%	111.13%	179.41%	90.05%
Interest Burden Percent	-21.67%	-863.75%	15.98%	1.37%	30.60%	17.69%	20.14%	56.47%	64.36%	68.20%	71.72%
Effective Tax Rate	0.00%	0.00%	-94.90%	1,252.89%	36.31%	-2.67%	12.66%	24.43%	28.78%	10.32%	7.39%
Return on Invested Capital (ROIC)	4.24%	0.00%	0.00%	0.00%	4.42%	5.52%	4.18%	6.51%	7.48%	11.08%	11.90%
ROIC Less NNEP Spread (ROIC-NNEP)	2.70%	0.00%	0.00%	0.00%	3.28%	4.50%	3.55%	6.04%	7.50%	13.20%	9.94%
Return on Net Nonoperating Assets (RNNOA)	15.78%	0.00%	0.00%	0.00%	8.91%	6.22%	5.04%	8.23%	8.36%	13.42%	9.74%
Return on Equity (ROE)	20.02%	0.00%	0.00%	0.00%	13.33%	11.74%	9.22%	14.75%	15.84%	24.51%	21.64%
Cash Return on Invested Capital (CROIC)	-97.54%	0.00%	0.00%	0.00%	2.53%	16.61%	22.27%	26.02%	4.48%	5.88%	5.85%
Operating Return on Assets (OROA)	4.59%	0.00%	0.00%	0.00%	5.09%	3.64%	3.36%	5.92%	6.37%	7.61%	8.11%
Return on Assets (ROA)	-0.48%	0.00%	0.00%	0.00%	0.99%	2.08%	1.90%	3.72%	4.56%	9.31%	5.24%
Return on Common Equity (ROCE)	19.11%	0.00%	0.00%	0.00%	13.14%	11.70%	9.19%	14.72%	15.78%	24.41%	21.57%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	0.00%	3.25%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	48	5.65	122	-655	50	52	42	66	77	109	121
NOPAT Margin	2.01%	0.22%	4.46%	-22.54%	1.65%	1.81%	1.35%	1.99%	2.17%	3.01%	3.12%
Net Nonoperating Expense Percent (NNEP)	1.54%	4.11%	7.28%	-45.48%	1.14%	1.02%	0.63%	0.48%	-0.02%	-2.12%	1.96%
Return On Investment Capital (ROIC_SIMPLE)	1.14%	-	-	-	1.18%	1.19%	0.96%	1.48%	1.70%	2.35%	2.75%
Cost of Revenue to Revenue	84.47%	85.66%	85.75%	85.96%	86.18%	88.24%	88.09%	88.24%	88.38%	86.66%	87.28%
SG&A Expenses to Revenue	12.65%	14.02%	11.96%	12.08%	11.23%	9.99%	10.37%	9.12%	8.57%	9.98%	9.36%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	12.65%	14.02%	11.96%	12.08%	11.23%	9.99%	10.37%	9.12%	8.57%	9.98%	9.36%
Earnings before Interest and Taxes (EBIT)	68	8.07	62	57	79	51	49	88	108	121	130
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	124	61	115	110	137	96	93	131	150	163	175
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.19	0.37	1.22	1.56	1.80	1.88	2.36	2.88	3.60	4.17	6.60
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.08	0.00	0.00	0.00	0.26	0.27	0.33	0.39	0.52	0.60	0.94
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	55.31	62.74	40.41	35.42	26.61	36.95
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	1.81%	1.59%	2.47%	2.82%	3.76%	2.71%
Enterprise Value to Invested Capital (EV/IC)	1.03	0.76	1.08	1.20	1.31	1.58	1.82	2.11	2.48	2.67	3.99
Enterprise Value to Revenue (EV/Rev)	0.49	0.00	0.00	0.00	0.49	0.49	0.53	0.58	0.72	0.73	1.07
Enterprise Value to EBITDA (EV/EBITDA)	11.60	0.00	0.00	0.00	13.11	12.05	13.91	14.58	19.83	18.60	24.71
Enterprise Value to EBIT (EV/EBIT)	29.19	0.00	0.00	0.00	26.86	21.26	23.77	22.74	31.62	27.37	34.21
Enterprise Value to NOPAT (EV/NOPAT)	41.70	0.00	0.00	0.00	38.37	26.98	37.79	29.13	41.62	34.13	40.78
Enterprise Value to Operating Cash Flow (EV/OCF)	20.38	0.00	0.00	0.00	233.17	28.36	25.00	22.21	19.04	19.58	30.25
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	52.08	8.97	7.44	7.33	55.71	45.94	69.56
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	5.86	1.64	1.76	1.78	1.60	1.58	1.53	1.46	1.41	1.33	1.14
Long-Term Debt to Equity	5.81	1.61	1.73	1.75	1.57	1.55	1.50	1.43	1.38	1.30	1.11
Financial Leverage	5.84	1.61	1.75	1.76	2.72	1.38	1.42	1.36	1.11	1.02	0.98
Leverage Ratio	9.03	3.59	3.49	3.57	5.06	3.52	3.45	3.44	3.49	3.28	3.14
Compound Leverage Factor	-1.96	-31.03	0.56	0.05	1.55	0.62	0.69	1.94	2.24	2.24	2.25
Debt to Total Capital	85.42%	62.18%	63.81%	64.00%	61.48%	61.27%	60.47%	59.33%	58.49%	57.09%	53.16%
Short-Term Debt to Total Capital	0.77%	1.17%	1.10%	1.09%	1.14%	1.12%	1.15%	1.16%	1.15%	1.14%	0.94%
Long-Term Debt to Total Capital	84.65%	61.01%	62.72%	62.91%	60.34%	60.16%	59.31%	58.17%	57.33%	55.95%	52.22%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.66%	0.16%	0.14%	0.10%	0.09%	0.07%	0.06%	0.05%	0.25%	0.23%	0.22%
Common Equity to Total Capital	13.92%	37.66%	36.04%	35.90%	38.44%	38.65%	39.48%	40.62%	41.27%	42.68%	46.62%
Debt to EBITDA	9.69	0.00	0.00	0.00	6.23	5.57	5.53	5.00	5.65	4.92	3.77
Net Debt to EBITDA	9.65	0.00	0.00	0.00	6.09	5.46	5.39	4.73	5.46	3.27	2.88
Long-Term Debt to EBITDA	9.60	0.00	0.00	0.00	6.12	5.46	5.43	4.90	5.53	4.82	3.70
Debt to NOPAT	34.83	0.00	0.00	0.00	18.24	12.46	15.03	9.98	11.85	9.02	6.22
Net Debt to NOPAT	34.70	0.00	0.00	0.00	17.82	12.22	14.63	9.45	11.45	5.99	4.75
Long-Term Debt to NOPAT	34.52	0.00	0.00	0.00	17.91	12.24	14.74	9.78	11.61	8.84	6.11
Altman Z-Score	1.72	0.10	0.35	0.43	2.40	2.69	2.92	3.21	3.14	3.66	4.73
Noncontrolling Interest Sharing Ratio	4.54%	0.43%	0.39%	0.27%	1.39%	0.31%	0.26%	0.20%	0.42%	0.37%	0.32%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.17	1.26	1.33	1.35	1.33	1.73	1.76	1.79	1.57	1.74	1.59
Quick Ratio	0.72	0.84	0.88	0.84	0.76	0.71	0.69	0.74	0.58	1.29	1.09
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-4,099	-4,291	-5,117	12	483	767	858	20	33	-35
Operating Cash Flow to CapEx	964.71%	-361.47%	-64.12%	135.94%	591.81%	576.21%	200.93%	684.79%	614.79%	570.66%	151.27%
Free Cash Flow to Firm to Interest Expense	0.00	-52.72	-81.83	-91.27	0.22	11.57	19.77	22.44	0.53	0.87	-0.94
Operating Cash Flow to Interest Expense	1.96	-1.01	-0.29	0.49	1.65	2.43	1.27	2.82	6.01	3.18	1.19
Operating Cash Flow Less CapEx to Interest Expense	1.75	-1.29	-0.74	0.13	1.37	2.01	0.64	2.41	5.03	2.63	0.40
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.60	0.00	0.00	0.00	1.97	2.06	2.18	2.25	2.09	2.26	2.41
Accounts Receivable Turnover	10.01	0.00	0.00	0.00	11.80	12.06	12.84	13.05	13.64	13.07	13.61
Inventory Turnover	18.35	0.00	0.00	0.00	18.55	22.54	21.75	20.64	15.70	21.91	20.98
Fixed Asset Turnover	35.89	0.00	0.00	0.00	45.41	56.08	59.40	62.74	67.02	71.99	73.43
Accounts Payable Turnover	11.52	0.00	0.00	0.00	12.23	13.42	13.30	13.27	10.64	12.23	12.25
Days Sales Outstanding (DSO)	36.46	0.00	0.00	0.00	30.94	30.25	28.42	27.97	26.75	27.94	26.82
Days Inventory Outstanding (DIO)	19.89	0.00	0.00	0.00	19.67	16.20	16.78	17.68	23.26	16.66	17.40
Days Payable Outstanding (DPO)	31.68	0.00	0.00	0.00	29.85	27.20	27.44	27.50	34.31	29.84	29.80
Cash Conversion Cycle (CCC)	24.67	0.00	0.00	0.00	20.77	19.25	17.76	18.15	15.70	14.75	14.42
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,188	4,104	4,413	4,461	4,226	3,673	3,688	3,670	3,769	3,749	3,844
Invested Capital Turnover	2.11	0.00	0.00	0.00	2.68	3.05	3.10	3.27	3.45	3.68	3.82
Increase / (Decrease) in Invested Capital	0.00	4,104	4,413	4,461	38	-431	-724	-792	57	75	155
Enterprise Value (EV)	4,296	3,117	4,759	5,364	5,543	5,791	6,712	7,755	9,335	10,016	15,319
Market Capitalization	693	580	1,946	2,517	2,965	3,165	4,110	5,237	6,754	8,247	13,524
Book Value per Share	$4.96	$8.93	$9.34	$9.42	$9.46	$9.64	$10.00	$10.27	$10.40	$10.23	$10.56
Tangible Book Value per Share	($24.65)	($10.81)	($10.96)	($11.08)	($10.54)	($7.15)	($6.72)	($6.06)	($6.81)	($5.64)	($5.16)
Total Capital	4,201	4,163	4,438	4,497	4,287	4,365	4,415	4,477	4,544	4,637	4,394
Total Debt	3,588	2,588	2,832	2,878	2,636	2,675	2,670	2,656	2,658	2,648	2,336
Total Long-Term Debt	3,556	2,540	2,783	2,829	2,587	2,626	2,619	2,605	2,605	2,595	2,295
Net Debt	3,575	2,530	2,807	2,842	2,574	2,623	2,599	2,516	2,569	1,759	1,786
Capital Expenditures (CapEx)	17	22	24	20	15	18	24	16	38	22	29
Debt-free, Cash-free Net Working Capital (DFCFNWC)	227	318	400	459	452	1,067	1,123	1,142	1,009	305	405
Debt-free Net Working Capital (DFNWC)	240	376	426	495	513	1,120	1,193	1,282	1,097	1,194	956
Net Working Capital (NWC)	208	328	377	446	465	1,071	1,143	1,230	1,045	1,141	914
Net Nonoperating Expense (NNE)	55	52	102	-646	35	23	15	11	-0.33	-40	37
Net Nonoperating Obligations (NNO)	3,575	2,530	2,807	2,842	2,574	1,983	1,943	1,849	1,883	1,759	1,786
Total Depreciation and Amortization (D&A)	56	53	53	53	58	45	45	44	42	42	44
Debt-free, Cash-free Net Working Capital to Revenue	2.58%	0.00%	0.00%	0.00%	4.01%	9.00%	8.94%	8.58%	7.82%	2.24%	2.82%
Debt-free Net Working Capital to Revenue	2.72%	0.00%	0.00%	0.00%	4.56%	9.44%	9.50%	9.64%	8.50%	8.75%	6.65%
Net Working Capital to Revenue	2.36%	0.00%	0.00%	0.00%	4.12%	9.03%	9.09%	9.25%	8.09%	8.36%	6.36%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.05)	($0.26)	$0.10	($0.04)	$0.11	$0.15	$0.14	$0.27	$0.38	$0.73	$0.41
Adjusted Weighted Average Basic Shares Outstanding	117.87M	175.53M	197.52M	198.49M	193.00M	201.01M	201.81M	203.49M	202.56M	204.71M	206.04M
Adjusted Diluted Earnings per Share	($0.05)	($0.26)	$0.10	($0.04)	$0.11	$0.14	$0.13	$0.26	$0.34	$0.67	$0.38
Adjusted Weighted Average Diluted Shares Outstanding	117.87M	175.53M	208.99M	198.49M	193.00M	214.93M	216.34M	217.98M	219.77M	221.32M	220.28M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	171.32M	171.46M	174.13M	174.97M	174.25M	177.15M	180.35M	193.54M	193.92M	197.86M
Normalized Net Operating Profit after Tax (NOPAT)	48	5.65	44	40	50	36	42	66	77	109	121
Normalized NOPAT Margin	2.01%	0.22%	1.60%	1.37%	1.65%	1.23%	1.35%	1.99%	2.17%	3.01%	3.12%
Pre Tax Income Margin	-0.62%	-2.70%	0.37%	0.03%	0.79%	0.31%	0.31%	1.49%	1.96%	2.29%	2.41%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.82	0.10	1.19	1.01	1.44	1.21	1.25	2.30	2.81	3.15	3.54
NOPAT to Interest Expense	0.58	0.07	2.32	-11.69	0.92	1.25	1.09	1.74	2.00	2.82	3.27
EBIT Less CapEx to Interest Expense	0.62	-0.18	0.74	0.66	1.16	0.79	0.62	1.89	1.83	2.59	2.75
NOPAT Less CapEx to Interest Expense	0.37	-0.21	1.87	-12.05	0.64	0.83	0.46	1.32	1.02	2.26	2.49
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-0.41%	0.00%	0.00%	0.00%	-14.45%	13.56%	11.30%	4.01%	25.53%	33.42%	44.73%

Financials Breakdown Chart

Key Financial Trends

BrightSpring Health Services (NASDAQ: BTSG) showed solid top-line growth in Q1 2026, but the quarter also highlighted a highly leveraged balance sheet and a business that still depends heavily on debt and working-capital discipline.

Revenue rose to $3.61 billion in Q1 2026 from $3.55 billion in Q4 2025 and $2.88 billion in Q1 2025, showing the company continues to scale. Gross profit also improved to $482.2 million from $412.5 million a quarter earlier, and operating income increased to $121.4 million.

Profitability improved sharply year over year. Net income attributable to common shareholders reached $148.8 million in Q1 2026, up from $77.1 million in Q4 2025 and $29.5 million in Q1 2025. Earnings per share also moved higher, with basic EPS of $0.73 versus $0.38 in Q4 2025 and $0.15 a year ago.

Cash generation was another bright spot. BrightSpring produced $122.9 million in operating cash flow in Q1 2026, compared with $231.6 million in Q4 2025 and $101.6 million in Q1 2025. The company also reported a strong $800.3 million increase in cash and equivalents during the quarter, boosted by a very large divestiture-related inflow.

The balance sheet, however, remains the key risk. Total liabilities were $4.22 billion against $1.98 billion of equity, and long-term debt stood at $2.44 billion. Goodwill and intangible assets remain substantial at $2.53 billion and $536.9 million, respectively, so the company still carries significant acquisition-related assets.

Compared with the prior year, the balance sheet has improved in some ways, especially cash, but leverage is still elevated. BrightSpring had just $888.8 million in cash at the end of Q1 2026, versus $52.3 million at Q1 2025, yet debt remains large relative to equity and interest expense continues to absorb meaningful earnings power.

Revenue growth continued: Q1 2026 revenue of $3.61 billion was higher than both Q4 2025 and Q1 2025.
Gross profit improved: Gross profit rose to $482.2 million, indicating better underlying profitability.
Operating income expanded: Operating income increased to $121.4 million from $108.1 million in Q4 2025.
Net income jumped year over year: Common shareholder earnings climbed to $148.8 million.
Operating cash flow remained positive: BrightSpring generated $122.9 million from operations in Q1 2026.
Liquidity improved sharply: Cash and equivalents increased to $888.8 million.
Large divestiture inflow boosted cash: Investing cash flow was helped by $810.9 million from divestitures, which materially improved near-term liquidity.
Working capital remains important: Accounts receivable totaled $1.11 billion and inventories were $560.2 million, so cash conversion will matter.
Debt remains heavy: Long-term debt was still $2.44 billion, with additional short-term debt and lease obligations on top.
Balance sheet leverage is high: Total liabilities of $4.22 billion still exceed equity by a wide margin.

Bottom line: BrightSpring’s operating performance is trending in the right direction, and Q1 2026 showed better profitability and strong cash generation. But for retail investors, the stock still looks like a balance-sheet story as much as an earnings story: the company is growing, yet debt and acquisition-related assets make execution and cash flow consistency especially important.

08/06/26 03:51 AM ETAI Generated. May Contain Errors.

BrightSpring Health Services Financials - Frequently Asked Questions

According to the most recent income statement we have on file, BrightSpring Health Services' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

BrightSpring Health Services' net income appears to be on a downward trend, with a most recent value of $189.11 million in 2025, falling from -$54.22 million in 2022. The previous period was -$20.52 million in 2024. Check out BrightSpring Health Services' forecast to explore projected trends and price targets.

BrightSpring Health Services' total operating income in 2025 was $295.25 million, based on the following breakdown:

Total Gross Profit: $1.52 billion
Total Operating Expenses: $1.22 billion

Over the last 3 years, BrightSpring Health Services' total revenue changed from $7.72 billion in 2022 to $12.91 billion in 2025, a change of 67.2%.

BrightSpring Health Services' total liabilities were at $4.53 billion at the end of 2025, a 5.9% increase from 2024, and a 8.0% decrease since 2023.

In the past 2 years, BrightSpring Health Services' cash and equivalents has ranged from $13.07 million in 2023 to $88.37 million in 2025, and is currently $88.37 million as of their latest financial filing in 2025.

Over the last 3 years, BrightSpring Health Services' book value per share changed from 0.00 in 2022 to 10.40 in 2025, a change of 1,039.7%.

Related Companies

Financial statements for NASDAQ:BTSGU last updated on 7/31/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BrightSpring Health Services (BTSGU) Financials

Financials Breakdown Chart

Key Financial Trends

BrightSpring Health Services Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BrightSpring Health Services (BTSGU) Financials

Annual Income Statements for BrightSpring Health Services

Quarterly Income Statements for BrightSpring Health Services

Annual Cash Flow Statements for BrightSpring Health Services

Quarterly Cash Flow Statements for BrightSpring Health Services

Annual Balance Sheets for BrightSpring Health Services

Quarterly Balance Sheets for BrightSpring Health Services

Annual Metrics And Ratios for BrightSpring Health Services

Quarterly Metrics And Ratios for BrightSpring Health Services

Financials Breakdown Chart

Key Financial Trends

BrightSpring Health Services Financials - Frequently Asked Questions

When does BrightSpring Health Services' financial year end?

How has BrightSpring Health Services' net income changed over the last 3 years?

What is BrightSpring Health Services' operating income?

How has BrightSpring Health Services' revenue changed over the last 3 years?

How much debt does BrightSpring Health Services have?

How much cash does BrightSpring Health Services have?

How has BrightSpring Health Services' book value per share changed over the last 3 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools